Table 4 Patient Access to Health Services during COVID-19, by Disease Category and Geographical Region, 2020
| Â | Â | Â | Disease Category | Â | Â | Â | Geographical Region | Â | Total | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
|  | Auto- immune | Cancer  | Multiple Sclerosis | Rare Disease | Other NCDs | Andean Region   | Brazil | Central America and Cuba | Mexico | Southern Cone     |  |
| Â | Â | Â | Â | Â | Â | n/N (%) | Â | Â | Â | Â | Â |
Telemedicinea | Â | ||||||||||
Accessed, private | 1/12 (8.3) | 5/30 (16.7) | 2/17 (11.8) | 5/9 (55.6) | 2/13 (15.4) | 1/22 (4.6) | 5/11 (45.5) | 2/19 (10.5) | 2/18 (11.1) | 5/11 (45.5) | 15/81 (18.5) |
Accessed, public | 2/12 (16.7) | 5/30 (16.7) | 4/17 (23.5) | 1/9 (11.1) | 2/13 (15.4) | 8/22 (36.4) | 0 | 2/19 (10.5) | 3/18 (16.7) | 1/11 (9.1) | 14/81 (17.3) |
Accessed, private/public | 2/12 (16.7) | 7/30 (23.3) | 1/17 (5.9) | 0 | 1/13 (7.7) | 3/22 (13.6) | 2/11 (18.2) | 4/19 (21.1) | 0 | 2/11 (18.2) | 11/81 (13.6) |
Not accessible | 5/12 (41.7) | 10/30 (33.3) | 5/17 (29.4) | 3/9 (33.3) | 7/13 (53.9) | 10/22 (45.5) | 4/11 (36.4) | 4/19 (21.1) | 9/18 (50.0) | 3/11 (27.3) | 30/81 (37.0) |
Not available | 2/12 (16.7) | 3/30 (10.0) | 5/17 (29.4) | 0 | 1/13 (7.7) | 0 | 0 | 7/19 (36.8) | 4/18 (22.2) | 0 | 11/81 (13.6) |
Electronic Prescriptionsa | Â | ||||||||||
Received, filled | 2/12 (16.7) | 7/30 (23.3) | 5/17 (29.4) | 4/8(50.0) | 1/12 (8.3) | 6/21 (28.6) | 0 | 8/18 (44.4) | 2/18 (11.1) | 3/11 (27.3) | 19/79 (24.1) |
Received, not filled | 3/12 (25.0) | 4/30 (13.3) | 5/17 (29.4) | 3/8 (37.5) | 2/12 (16.7) | 10/21 (47.6) | 1/11 (9.1) | 2/18 (11.1) | 0 | 4/11 (36.4) | 17/79 (21.5) |
Not received | 3/12 (25.0) | 13/30 (43.3) | 2/17 (11.8) | 0 | 6/12 (50.0) | 3/21 (14.3) | 10/11 (90.9) | 1/18 (5.6) | 7/18 (38.9) | 3/11 (27.3) | 24/79 (30.4) |
Not available | 4/12 (33.3) | 6/30 (20.0) | 5/17 (29.4) | 1/8 (12.5) | 3/12 (25.0) | 2/21 (9.5) | 0 | 7/18 (38.9) | 9/18 (50.0) | 1/11 (9.1) | 19/79 (24.1) |
Multi-Month Scripting and Dispensinga | Â | ||||||||||
Prescribed, filled | 7/12 (58.3) | 6/30 (20.0) | 9/15 (60.0) | 2/8 (25.0) | 4/12 (33.3) | 8/20 (40.0) | 4/11 (36.4) | 9/17 (52.9) | 4/18 (22.2) | 3/11 (27.3) | 28/77 (36.4) |
Prescribed, not filled | 2/12 (16.7) | 9/30 (30.0) | 3/15 (20.0) | 2/8 (25.0) | 4/12 (33.3) | 9/20 (45.0) | 2/11 (18.2) | 2/17 (11.8) | 6/18 (33.3) | 1/11 (9.1) | 20/77 (26.0) |
Not prescribed | 3/12 (25.0) | 15/30 (50.0) | 3/15 (20.0) | 4/8(50.0) | 4/12 (33.3) | 3/20 (15.0) | 5/11 (45.5) | 6/17 (35.3) | 8/18 (44.4) | 7/11 (63.6) | 29/77 (37.7) |
Palliative Careb | Â | ||||||||||
Available | 5/8 (62.5) | 11/23 (47.8) | 9/10 (90.0) | 2/4 (50.0) | 3/7 (42.9) | 7/13 (53.9) | 6/7 (85.7) | 7/13 (53.9) | 4/11 (36.4) | 6/8 (75.0) | 30/52 (57.7) |
Not Available | 3/8 (37.5) | 12/23 (52.2) | 1/10 (10.0) | 2/4 (50.0) | 4/7 (57.1) | 6/13 (46.2) | 1/7 (14.3) | 6/13 (46.2) | 7/11 (63.6) | 2/8 (25.0) | 22/52 (42.3) |